Tenn. Code § 39-17-406

Current through Acts 2023-2024, ch. 1069

Section 39-17-406 - Controlled substances in Schedule I

(a) Schedule I consists of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(b) Opiates, unless specifically excepted or unless listed in another schedule, means any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation; provided, that for the purposes of subdivision (b)(48)(B)(xv), 3-Methylfentanyl, only, "isomer" includes the optical and geometric isomers:

(1) Acetylmethadol;

(2) Allylprodine;

(3) Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol; levomethadyl acetate; or LAAM);

(4) Alphameprodine;

(5) Alphamethadol;

(6) Benzethidine;

(7) Betacetylmethadol;

(8) Betameprodine;

(9) Betamethadol;

(10) Betaprodine;

(11) Clonitazene;

(12) Dextromoramide;

(13) Diampromide;

(14) Diethylthiambutene;

(15) Difenoxin;

(16) Dimenoxadol;

(17) Dimepheptanol;

(18) Dimethylthiambutene;

(19) Dioxaphetyl butyrate;

(20) Dipipanone;

(21) Ethylmethylthiambutene;

(22) Etonitazene;

(23) Etoxeridine;

(24) Furethidine;

(25) Hydroxypethidine;

(26) Ketobemidone;

(27) Levomoramide;

(28) Levophenacylmorphan;

(29) Morpheridine;

(30) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

(31) Noracymethadol;

(32) Norlevorphanol;

(33) Normethadone;

(34) Norpipanone;

(35) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);

(36) Phenadoxone;

(37) Phenampromide;

(38) Phenomorphan;

(39) Phenoperidine;

(40) Piritramide;

(41) Proheptazine;

(42) Properidine;

(43) Propiram;

(44) Racemoramide;

(45) Tilidine;

(46) Trimeperidine;

(47) U-47700; or

(48) Fentanyl derivatives and analogues:

(A) Unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States food and drug administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations containing a 4-anilidopiperidine structure:

(i) With or without substitution at the carbonyl of the aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl, methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl, dihydrofuranyl, benzyl moiety, or rings containing heteroatoms sulfur, oxygen, or nitrogen;

(ii) With or without substitution at the piperidine amino moiety with a phenethyl, benzyl, alkylaryl (including heteroaromatics), alkyltetrazolyl ring, or an alkyl or carbomethoxy group, whether or not further substituted in the ring or group;

(iii) With or without substitution or addition to the piperdine ring to any extent with one or more methyl, carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester groups;

(iv) With or without substitution of one or more hydrogen atoms for halogens, or methyl, alkyl, or methoxy groups, in the aromatic ring of the anilide moiety;

(v) With or without substitution at the alpha or beta position of the piperidine ring with alkyl, hydroxyl, or methoxy groups;

(vi) With or without substitution of the benzene ring of the anilide moiety for an aromatic heterocycle; or

(vii) With or without substitution of the piperidine ring for a pyrrolidine ring, perhydroazepine ring, or azepine ring; and

(B) The application of subdivision (b)(48)(A) includes, but is not limited to, any of the following:

(i) Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);

(ii) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidnyl]-N-phenyl-acetamide);

(iii) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide);

(iv) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);

(v) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);

(vi) Benzodioxolefentanyl;

(vii) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);

(viii) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide); N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide);

(ix) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);

(x) Butyrylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

(xi) Cyclopentyl fentanyl;

(xii) Isobutyryl fentanyl;

(xiii) Furanyl fentanyl;

(xiv) Lofentanil;

(xv) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);

(xvi) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);

(xvii) Ocfentanil;

(xviii) Ohmefentanyl;

(xix) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide);

(xx) Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; 4-fluoroisobutyryl fentanyl;

(xxi) Pentanoyl fentanyl;

(xxii) Thiofentanyl; or

(xxiii) Valeryl fentanyl.

(c) Opium derivatives, unless specifically excepted or unless listed in another schedule, means any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Acetorphine;

(2) Acetyldihydrocodeine;

(3) Benzylmorphine;

(4) Codeine methylbromide;

(5) Codeine-N-Oxide;

(6) Cyprenorphine;

(7) Desomorphine;

(8) Dihydromorphine;

(9) Drotebanol;

(10) Etorphine (except hydrochloride salt);

(11) Heroin;

(12) Hydromorphinol;

(13) Methyldesorphine;

(14) Methyldihydromorphine;

(15) Morphine methylbromide;

(16) Morphine methylsulfonate;

(17) Morphine-N-Oxide;

(18) Myrophine;

(19) Nicocodeine;

(20) Nicomorphine;

(21) Normorphine;

(22) Pholcodine; or

(23) Thebacon.

(d) Hallucinogenic substances, unless specifically excepted or unless listed in another schedule, means any material, compound mixture, or preparation that contains any quantity of the following hallucinogenic substances, or that contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specified chemical designation; provided, that for purposes of this subsection (d) only, "isomer" includes the optical, positional, and geometric isomers:

(1) Alpha-ethyltryptamine

Other names: etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; [alpha]-ET; and AET; ET; Trip;

(2) Alpha-methyltryptamine

Other name: AMT;

(3) 4-Bromo-2,5-dimethoxyamphetamine

Other names: 4-Bromo-2,5-dimethoxy-[alpha]-methylphenethylamine; 4-bromo-2,5-DMA;

(4) 4-Bromo-2,5-dimethoxyphenethylamine

Other names: 2-(4-Bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B; Nexus;

(5) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

Other names: 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36;

(6) Bufotenine

Other names: 3-([beta]-Dimethylaminoethyl)-5-hydroxyindole; 3-(2 dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;

(7) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

Other names: 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82;

(8) Diethyltryptamine

Other names: N,N-Diethyltryptamine; DET;

(9) 2,5-Dimethoxyamphetamine

Other names: 2,5-Dimethoxy-[alpha]-methylphenethylamine; 2,5-DMA;

(10) 2,5-Dimethoxy-4-ethylamphetamine

Other name: DOET;

(11) 2,5 Dimethoxy-4-(n)-propylthiophenethylamine

Other name: 2C-T-7;

(12) Dimethyltryptamine

Other name: DMT;

(13) Ethylamine analogue of phencyclidine

Other names: N-Ethyl-1-phenylcyclohexylamine; (1-phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE;

(14) Ibogaine

Other names: 7-Ethyl-6,6[beta],7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1',2':1,2]azepino[5,4-b]indole; Tabenanthe iboga;

(15) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

Other names: 25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5;

(16) Lysergic acid diethylamide

Other name: LSD;

(17) Mescaline

Other name: Constituent of "Peyote" cacti;

(18) 4-Methoxyamphetamine

Other names: 4-methoxy-[alpha]-methylphenethylamine; paramethoxyamphetamine; PMA;

(19) 5-Methoxy-3,4-methylenedioxyamphetamine;

(20) 5-Methoxy-N,N-diisopropyltryptamine

Other name: 5-MeO-DIPT;

(21) 5-methoxy-N,N-dimethyltryptamine

Other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT;

(22) 4-Methyl-2,5-dimethoxyamphetamine

Other names: 4-methyl-2,5-dimethoxy-[alpha]-methylphenethylamine; DOM; STP;

(23) 3,4-Methylenedioxyamphetamine;

(24) 3,4-Methylenedioxymethamphetamine

Other name: MDMA;

(25) 3,4-Methylenedioxy-N-ethylamphetamine

Other names: N-ethyl-alpha-methyl 3,4(methylenedioxy) phenethylamine; N-ethyl MDA; MDE; MDEA;

(26) 3,4-Methylenedioxy-N-methylcathinone

Other name: Methylone;

(27) N-Ethyl-3-piperidyl benzilate;

(28) N-Hydroxy-3,4-methylenedioxyamphetamine

Other names: N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-hydroxy MDA;

(29) N-methyl-3-piperidyl benzilate;

(30) Parahexyl

Other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;

(31) Peyote

Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lamaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant or its seeds or extracts (Interprets 21 U.S.C. § 812(c), Schedule l(c)(12));

(32) Psilocybin (constituent of magic mushrooms);

(33) Psilocyn (constituent of magic mushrooms);

(34) Pyrrolidine analogue of phencyclidine (1-(1-phenylcyclohexyl)-pyrrolidine)

Other names: PCPy; PHP;

(35) 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine

Other name: TCPy;

(36) 4-Methylmethcathinone

Other names: mephedrone; methpadrone; 4-MMC;

(37) 3,4-Methylenedioxypyrovalerone

Other name: MDPV;

(38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);

(39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);

(40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);

(41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);

(42) 2-[4-Ethylthio-2,5-dimethoxyphenyl]ethanamine (2C-T-2);

(43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);

(44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);

(45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);

(46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);

(47) Thiophene analogue of phencyclidine

Other names: 1-[1-(2-thienyl)cyclohexyl]piperidine; 2-thienylanalog of phencyclidine; TPCP; TCP;

(48) 3,4,5-Trimethoxyamphetamine;

(49) (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

Other names: UR-144; 1-pentyl-3-(2,2,3,3 tetramethylcyclopropoyl)indole; or

(50) [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone

Other names: 5-fluoro-UR-144; 5-F-UR-144; XLR-11 1-(5-fluoro-pentyl)-3- (2,2,3,3-tetramethylcyclopropoyl)indole.

(e) Depressants, unless specifically excepted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specified chemical designation:

(1) Etizolam

Other names: Etilaam, Etizola, Sedekopan, Pasaden, Depas;

(2) Gamma-hydroxybutyric acid

Other names: GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate;

(3) Mecloqualone; or

(4) Methaqualone.

(f) Stimulants, unless specifically excepted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

(1) Alpha-pyrrolidinobutiophenone

Other names: [alpha]-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one;

(2) Alpha-pyrrolidinopentiophenone

Other names: [alpha]-PVP; [alpha]-pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one;

(3) Aminorex

Other names: aminoxophen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine;

(4) Butylone

Other names: bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one;

(5) Cathinone

Other names: 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone; 2-aminopropiophenone; norphedrone; constituent of catha edulis or "Khat" plant;

(6) 3-Fluoro-N-methylcathinone

Other names: 3-FMC; 1-(3-fluorophenyl)-2-(methylamino)propan-1-one;

(7) 4-Fluoro-N-methylcathinone

Other names: 4-FMC; flephedrone; 1-(4-fluorophenyl)-2-(methylamino)propan-1-one;

(8) Fenethylline;

(9) Methcathinone

Other names: 2-(methylamino)-propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR1432;

(10) (+/-)cis-4-Methylaminorex (cis isomer)

Other name: (+/-)cis-4,5 dihydro-4-methyl-5-phenyl-2-oxazolamine;

(11) 4-Methyl-N-ethylcathinone

Other names: 4-MEC; 2-(ethylamino)-1-(4-methylphenyl)propan-1-one;

(12) 4-Methyl-alpha-pyrrolidinopropiophenone

Other names: 4-MePPP; MePPP; 4-methyl-[alpha]-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one;

(13) Naphyrone

Other names: naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one;

(14) N-Benzylpiperazine

Other names: BZP; 1-benzylpiperazine;

(15) N-Ethylamphetamine;

(16) N,N-Dimethylamphetamine

Other names: N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine;

(17) Pentedrone

Other names: [alpha]-methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one; or

(18) Pentylone

Other names: bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one.

(g) Cannabimimetic agents, unless specifically exempted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances, or that contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);

(2) 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);

(3) 1-Pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);

(4) 1-Butyl-3-(1-naphthoyl)indole (JWH-073);

(5) 1-Hexyl-3-(1-naphthoyl)indole (JWH-019);

(6) 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);

(7) 1-Pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);

(8) 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);

(9) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);

(10) 1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);

(11) (1-(5-Fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ-2201);

(12) 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201);

(13) 1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);

(14) 1-Pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4);

(15) 1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8);

(16) 1-Pentyl-3-(2-chlorophenylacetyl)indole (JWH-203);

(17) Methyl 2-(1-(cyclohexylmethyl)-1h-indole-3-carboxamido)-3,3-dimethylbutanoate

Other names: MDMB-CHMICA, MMB-CHMINACA;

(18) Methyl 2-(1-(4-fluorobenzyl)-1h-indazole-3-carboxamido)-3,3-dimethylbutanoate

Other name: MDMB-FUBINACA;

(19) Methyl 2-(1-(5-fluoropentyl)-1h-indazole-3-carboxamido)-3-methylbutanoate

Other name: 5F-AMB;

(20) Methyl 2-(1-(5-fluoropentyl)-1h-indazole-3-carboxamido)-3,3-dimethylbutanoate

Other names: 5F-ADB, 5F-MDMB-PINACA;

(21) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide

Other names: APINACA; AKB48;

(22) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

Other names: 5F-APINACA, 5F-AKB48;

(23) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide

Other name: AB-FUBINACA;

(24) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3-carboxamide

Other name: AB-CHMINACA;

(25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)1H-indazole-3-carboxamide

Other name: ADB-FUBINACA;

(26) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

Other name: ADB-PINACA;

(27) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

Other name: AB-PINACA;

(28) Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

Other names: 5-fluoro-PB-22; 5F-PB-22; or

(29) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate

Other names: PB-22; QUPIC.

T.C.A. § 39-17-406

Amended by 2018 Tenn. Acts, ch. 1040,s 3, eff. 7/1/2018.

Amended by 2015 Tenn. Acts, ch. 302,s 1, eff. 7/1/2015.

Amended by 2014 Tenn. Acts, ch. 735,s 2, eff. 7/1/2014.

Acts 1989, ch. 591, § 1; 1997, ch. 107, § 1; 1997, ch. 149, § 1; 2007, ch. 298, §§ 1-4; 2012, ch. 812, § 1.